REFERENCE
Clifford DB, DeLuca A, Simpson D, Arendt G, Giovannoni G, Nath A.Progressive Multifocal Leukoencephalopathy with Natalizumab Treatment of Multiple Sclerosis. 62nd Annual Meeting of the American Academy of Neurology: abstr. PL01.003, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan
Frenay CL, Debouverie M, Brassat D, Vermersch P, Defer G, de Seze J, Clavelou P, Heinzlef O, Rumbach L, Wiertlevski S, Tourniaire P, Berthier F.Cancer Risk among Patients with Multiple Sclerosis during the Treatment Era: The CARIMS Study Update. 62nd Annual Meeting of the American Academy of Neurology: abstr. P06.135, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan
Savettieri G, Aridon P, D'Amelio M, Mazzola MA, Realmuto S, Zummo L, Salemi G, Ragonese P.Frequency of mitoxantrone related heart involvement in patients affected by multiple sclerosis. 62nd Annual Meeting of the American Academy of Neurology: abstr. P06.140, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan
Ionete C, Ebuh V, Singh A, Kane K, Lavallee J, Riskind P, Zawacki J.Central Demyelination Complicating the Use of Anti-TNF? in the Treatment of Inflammatory Bowel Disease(IBD): A Retrospective Study. 62nd Annual Meeting of the American Academy of Neurology: abstr. P06.166, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan
Rocher F, Laffon M, Cohen M, Frenay CL.Hypereosinophilia with natalizumab. 62nd Annual Meeting of the American Academy of Neurology: abstr. P04.194, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan
Hutton GJ, Avila M, Prieto PG, Avila J, Rivera VM.Multiple Sclerosis and Other CNS Demyelination after Treatment with Tumor Necrosis Factor alpha Blockers. 62nd Annual Meeting of the American Academy of Neurology: abstr. P04.215, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan
Al-Sabbagh A, Dawson D, Bennett R, Dangond F.Acute leukemia in multiple sclerosis patients treated with mitoxantrone in the postmarketing setting: The EMD Serono experience. 62nd Annual Meeting of the American Academy of Neurology: abstr. P01.170, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan
Dangond F, Dawson D, Beagan J, Bock D, Chang P, Yang Y, Bennett R, Al-Sabbagh A.Cardiovascular adverse events with mitoxantrone: Results from the registry to evaluate novantrone effects in worsening multiple sclerosis (RENEW) study. 62nd Annual Meeting of the American Academy of Neurology: abstr. P01.171, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan
Rights and permissions
About this article
Cite this article
Multiple sclerosis news from AAN. React. Wkly. 1300, 3–4 (2010). https://doi.org/10.2165/00128415-201013000-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201013000-00006